PTC Therapeutics
PTCT
#2715
Rank
โ‚น626.61 B
Marketcap
โ‚น7,554
Share price
-0.27%
Change (1 day)
85.65%
Change (1 year)

Revenue for PTC Therapeutics (PTCT)

Revenue in 2026 (TTM): โ‚น74.34 Billion

According to PTC Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚น79.85 Billion. In 2025 the company made a revenue of โ‚น155.35 Billion an increase over the revenue in the year 2024 that were of โ‚น69.21 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for PTC Therapeutics from 2012 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น74.34 B-52.15%
2025 โ‚น155.35 B124.47%
2024 โ‚น69.21 B-11.35%
2023 โ‚น78.07 B35.01%
2022 โ‚น57.82 B44.25%
2021 โ‚น40.08 B43.96%
2020 โ‚น27.84 B27.21%
2019 โ‚น21.89 B18.26%
2018 โ‚น18.51 B49.14%
2017 โ‚น12.41 B120.85%
2016 โ‚น5.62 B115.47%
2015 โ‚น2.60 B79.21%
2014 โ‚น1.45 B-24.8%
2013 โ‚น1.93 B22.82%
2012 โ‚น1.57 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Novartis
NVS
โ‚น5.462 T 6,740.44%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
โ‚น1.179 T 1,377.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
โ‚น9.40 B-88.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚น210.88 B 164.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
โ‚น0.60 B-99.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
โ‚น1.81 B-97.73%๐Ÿ‡บ๐Ÿ‡ธ USA